UBS Initiates Coverage On Xylem with Buy Rating, Announces Price Target of $165
Portfolio Pulse from Benzinga Newsdesk
UBS analyst Damian Karas has initiated coverage on Xylem (NYSE:XYL) with a Buy rating and set a price target of $165.

August 13, 2024 | 10:56 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
UBS analyst Damian Karas has initiated coverage on Xylem with a Buy rating and set a price target of $165.
The initiation of coverage with a Buy rating and a price target of $165 by a reputable analyst from UBS is likely to positively impact Xylem's stock price in the short term. Such analyst ratings often influence investor sentiment and can lead to increased buying activity.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100